Calling cancer’s bluff with neoantigen vaccines

Sarah DeWeerdt

Nature, 2017, vol. 552, issue 7685, S76-S77

Abstract: State-of-the art tumour-genome sequencing and analysis is enabling researchers to provide uniquely personalized immunotherapy.

Keywords: Therapeutics; Cancer; Personalized medicine; Vaccines (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-017-08706-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:552:y:2017:i:7685:d:10.1038_d41586-017-08706-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-017-08706-3

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().